Improved gut comfort in patients with GI issues
Originally developed for neurodegenerative diseases like Alzheimers, Dihexa is now emerging as a cornerstone of modern anti-aging therapy
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
A very nostalgic game
Thats a disorder that affects how the brain develops
The 5 initial loading doses are usually all that is needed for long lasting protection